Health · 37 views
GLP-1 medications linked to fewer deaths and amputations in people with type 2 diabetes and PAD
According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with type 2…
Summary
According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist (GLP-1 RA) medications reduce the number of deaths, amputations and hospitalizations among people with type 2 diabetes who also have narrowed leg arteries associated with PAD (peripheral artery disease).
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Study identifies potential new treatment targets for the most common type of bowel cancerContinue reading
- STAT+: Diabetes association says ‘threat’ preceded members’ ejections, but admits policies were unclearContinue reading
- Infants' Maternal Measles Protection May Not Last Until First MMR DoseContinue reading
- What Did Leaked Data on an mRNA Vaccine Show?Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow